TAMPA, Fla. - Moffitt Cancer Center is hosting its 17th-annual Ted Couch Cancer Research Lecture on Wednesday, Nov. 18 at 4 p.m. at the Vincent A. Stabile Research Building, 12902 Magnolia Drive. Charles L. Sawyers, M.D., who serves as the Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, will give a free public lecture on his studies of mechanisms of drug resistance in cancer and his work in developing new drugs for cancer treatment.
Dr. Sawyers is a co-developer of Gleevec®, a drug that treats certain types of leukemia, and he co-discovered the anti-androgen drug Enzalutamide, which is used to treat prostate cancer. His research has significantly contributed to understanding the progression of cancer, and his findings in drug resistance and work in developing new targeted anti-cancer drugs has made him a leader in his field.
Dr. Sawyers is a member of the National Academy of Sciences, and of the Institute of Medicine. He received the 2013 Breakthrough Prize in Life Sciences, the 2013 Taubman Prize for Excellence in Translational Medical Science and the 2015 BBVA Knowledge Award in Biomedicine. He is a past President of the American Association for Cancer Research and was appointed to the National Cancer Advisory Board by President Barack Obama.
A cocktail reception will follow the presentation. Please RSVP to 1-888-MOFFITT (1-888-663-3488).
About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in Florida and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. With more than 4,600 team members, Moffitt has an economic impact in the state of $1.9 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.